| Epidemiology and pathophysiology of nephrotic syndrome–associated thromboembolic disease BA Kerlin, R Ayoob, WE Smoyer Clinical Journal of the American Society of Nephrology 7 (3), 513-520, 2012 | 411 | 2012 |
| An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo B Li, X Luo, B Deng, J Wang, DW McComb, Y Shi, KML Gaensler, X Tan, ... Nano letters 15 (12), 8099-8107, 2015 | 233 | 2015 |
| Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia BA Kerlin, SB Yan, BH Isermann, JT Brandt, R Sood, BR Basson, ... Blood 102 (9), 3085-3092, 2003 | 201 | 2003 |
| Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases BA Setty, SH O'Brien, BA Kerlin Pediatric blood & cancer 59 (2), 258-264, 2012 | 199 | 2012 |
| Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study BA Kerlin, NB Blatt, B Fuh, S Zhao, A Lehman, C Blanchong, JD Mahan, ... The Journal of pediatrics 155 (1), 105-110. e1, 2009 | 187 | 2009 |
| Characterization of a mouse model for thrombomodulin deficiency H Weiler, V Lindner, B Kerlin, BH Isermann, SB Hendrickson, BC Cooley, ... Arteriosclerosis, thrombosis, and vascular biology 21 (9), 1531-1537, 2001 | 172 | 2001 |
| AKI in children hospitalized with nephrotic syndrome MN Rheault, L Zhang, DT Selewski, M Kallash, CL Tran, M Seamon, ... Clinical Journal of the American Society of Nephrology 10 (12), 2110-2118, 2015 | 130 | 2015 |
| The emerging role of coagulation proteases in kidney disease T Madhusudhan, BA Kerlin, B Isermann Nature reviews nephrology 12 (2), 94, 2016 | 125 | 2016 |
| Cause-effect relation between hyperfibrinogenemia and vascular disease B Kerlin, BC Cooley, BH Isermann, I Hernandez, R Sood, M Zogg, ... Blood 103 (5), 1728-1734, 2004 | 118 | 2004 |
| The cost of pediatric stroke care and rehabilitation W Lo, K Zamel, K Ponnappa, A Allen, D Chisolm, M Tang, B Kerlin, ... Stroke 39 (1), 161-165, 2008 | 104 | 2008 |
| Venous thromboembolism in pediatric nephrotic syndrome BA Kerlin, K Haworth, WE Smoyer Pediatric nephrology 29, 989-997, 2014 | 102 | 2014 |
| Current and future management of pediatric venous thromboembolism BA Kerlin American journal of hematology 87 (S1), S68-S74, 2012 | 63 | 2012 |
| Role of direct oral anticoagulants in patients with kidney disease VK Derebail, MN Rheault, BA Kerlin Kidney international 97 (4), 664-675, 2020 | 62 | 2020 |
| Desmopressin responsiveness in children with Ehlers‐Danlos syndrome associated bleeding symptoms KJ Mast, ME Nunes, FB Ruymann, BA Kerlin British journal of haematology 144 (2), 230-233, 2009 | 61 | 2009 |
| Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome MN Rheault, CC Wei, DS Hains, W Wang, BA Kerlin, WE Smoyer Pediatric Nephrology 29, 139-147, 2014 | 53 | 2014 |
| Thrombin-induced podocyte injury is protease-activated receptor dependent R Sharma, AP Waller, S Agrawal, KJ Wolfgang, H Luu, K Shahzad, ... Journal of the American Society of Nephrology 28 (9), 2618-2630, 2017 | 44 | 2017 |
| Factor V Leiden polymorphism modifies sepsis outcome: evidence from animal studies H Weiler, B Kerlin, MC Lytle Critical care medicine 32 (5), S233-S238, 2004 | 44 | 2004 |
| Congenital amegakaryocytic thrombocytopenia: the diagnostic importance of combining pathology with molecular genetics MJ Rose, KK Nicol, MA Skeens, TG Gross, BA Kerlin Pediatric Blood & Cancer 50 (6), 1263-1265, 2008 | 43 | 2008 |
| Protease‐activated receptors: An illustrated review X Han, MT Nieman, BA Kerlin Research and practice in thrombosis and haemostasis 5 (1), 17-26, 2021 | 41 | 2021 |
| Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome SL Carpenter, J Goldman, AK Sherman, DT Selewski, M Kallash, CL Tran, ... Pediatric Nephrology 34, 261-267, 2019 | 38 | 2019 |
